Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
December 24, 2013
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types
Sandra J Engle, Fabien Vincent
Cell Stem Cell
|
June 11, 2013
Integrating human pluripotent stem cells into drug development
Sandra J Engle, Dinesh Puppala
Cell Stem Cell
|
September 3, 2021
Human inducible pluripotent stem cells: Realization of initial promise in drug discovery
Robin J Kleiman, Sandra J Engle
Neuron
|
November 23, 2018
Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons
Sandra J Engle, Laura Blaha, Robin J Kleiman
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Genetically engineered mouse models in drug discovery research
Rosalba Sacca, Sandra J Engle, Wenning Qin, et al.
Cellular Immunology
|
June 1, 2005
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice
Ramireddy Bommireddy, Sandra J Engle, Ilona Ormsby, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 2, 2018
Human Pluripotent Stem Cell-Derived Kidney Model for Nephrotoxicity Studies
Piyush Bajaj, A David Rodrigues, Claire M Steppan, et al.
Cancer Research
|
November 20, 2002
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice
Sandra J Engle, Ilona Ormsby, Sharon Pawlowski, et al.
Scientific Reports
|
November 20, 2015
The Specification and Maturation of Nociceptive Neurons from Human Embryonic Stem Cells
Erin M Boisvert, Sandra J Engle, Shawn E Hallowell, et al.
Scientific Reports
|
February 22, 2023
Investigation of SAMD1 ablation in mice
Bruce Campbell, Lisa M Weber, Sandra J Engle, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
December 24, 2013
Small molecule screening in human induced pluripotent stem cell-derived terminal cell types
Sandra J Engle, Fabien Vincent
Cell Stem Cell
|
June 11, 2013
Integrating human pluripotent stem cells into drug development
Sandra J Engle, Dinesh Puppala
Cell Stem Cell
|
September 3, 2021
Human inducible pluripotent stem cells: Realization of initial promise in drug discovery
Robin J Kleiman, Sandra J Engle
Neuron
|
November 23, 2018
Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons
Sandra J Engle, Laura Blaha, Robin J Kleiman
Methods in Molecular Biology (Clifton, N.J.)
|
December 17, 2009
Genetically engineered mouse models in drug discovery research
Rosalba Sacca, Sandra J Engle, Wenning Qin, et al.
Cellular Immunology
|
June 1, 2005
Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFbeta1-deficient mice
Ramireddy Bommireddy, Sandra J Engle, Ilona Ormsby, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 2, 2018
Human Pluripotent Stem Cell-Derived Kidney Model for Nephrotoxicity Studies
Piyush Bajaj, A David Rodrigues, Claire M Steppan, et al.
Cancer Research
|
November 20, 2002
Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice
Sandra J Engle, Ilona Ormsby, Sharon Pawlowski, et al.
Scientific Reports
|
November 20, 2015
The Specification and Maturation of Nociceptive Neurons from Human Embryonic Stem Cells
Erin M Boisvert, Sandra J Engle, Shawn E Hallowell, et al.
Scientific Reports
|
February 22, 2023
Investigation of SAMD1 ablation in mice
Bruce Campbell, Lisa M Weber, Sandra J Engle, et al.
Page
of 3